439 related articles for article (PubMed ID: 15909196)
1. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
Berthelsen AK; Holm S; Loft A; Klausen TL; Andersen F; Højgaard L
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1167-75. PubMed ID: 15909196
[TBL] [Abstract][Full Text] [Related]
2. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
3. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
Visvikis D; Costa DC; Croasdale I; Lonn AH; Bomanji J; Gacinovic S; Ell PJ
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):344-53. PubMed ID: 12634961
[TBL] [Abstract][Full Text] [Related]
4. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
[TBL] [Abstract][Full Text] [Related]
5. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
Beyer T; Antoch G; Bockisch A; Stattaus J
J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
[TBL] [Abstract][Full Text] [Related]
6. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
[TBL] [Abstract][Full Text] [Related]
7. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
[TBL] [Abstract][Full Text] [Related]
9. Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET.
Ay MR; Zaidi H
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1301-13. PubMed ID: 16622710
[TBL] [Abstract][Full Text] [Related]
10. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
11. Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET.
Souvatzoglou M; Ziegler SI; Martinez MJ; Busch R; Dzewas G; Schwaiger M; Bengel F
Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):405-12. PubMed ID: 16953402
[TBL] [Abstract][Full Text] [Related]
12. PET/CT: artifacts caused by bowel motion.
Nakamoto Y; Chin BB; Cohade C; Osman M; Tatsumi M; Wahl RL
Nucl Med Commun; 2004 Mar; 25(3):221-5. PubMed ID: 15094438
[TBL] [Abstract][Full Text] [Related]
13. Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT.
Büther F; Stegger L; Dawood M; Range F; Schäfers M; Fischbach R; Wichter T; Schober O; Schäfers KP
J Nucl Med; 2007 Jul; 48(7):1060-8. PubMed ID: 17574981
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
Mawlawi O; Erasmus JJ; Munden RF; Pan T; Knight AE; Macapinlac HA; Podoloff DA; Chasen M
AJR Am J Roentgenol; 2006 Feb; 186(2):308-19. PubMed ID: 16423932
[TBL] [Abstract][Full Text] [Related]
15. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Beyer T; Bockisch A; Kühl H; Martinez MJ
J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
[TBL] [Abstract][Full Text] [Related]
16. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
[TBL] [Abstract][Full Text] [Related]
18. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows.
Beyer T; Rosenbaum S; Veit P; Stattaus J; Müller SP; Difilippo FP; Schöder H; Mawlawi O; Roberts F; Bockisch A; Kühl H
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1429-39. PubMed ID: 16133383
[TBL] [Abstract][Full Text] [Related]
19. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR.
Schramm G; Maus J; Hofheinz F; Petr J; Lougovski A; Beuthien-Baumann B; Oehme L; Platzek I; van den Hoff J
Med Phys; 2015 Nov; 42(11):6468-76. PubMed ID: 26520736
[TBL] [Abstract][Full Text] [Related]
20. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]